BBLG
NASDAQ · Biotechnology
Bone Biologics Corp
$1.40
+0.04 (+2.56%)
Open$1.33
Previous Close$1.37
Day High$1.44
Day Low$1.30
52W High$19.63
52W Low$12.26
Volume—
Avg Volume736.1K
Market Cap2.51M
P/E Ratio49.74
EPS$0.32
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,413.6% upside
Current
$1.40
$1.40
Target
$21.19
$21.19
$14.35
$21.19 avg
$22.63
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 842.6K | 775.9K | 707.6K |
| Net Income | 53.5K | 41.0K | 38.8K |
| Profit Margin | 6.3% | 5.3% | 5.5% |
| EBITDA | 84.6K | 70.9K | 63.0K |
| Free Cash Flow | 39.3K | 30.9K | 34.5K |
| Rev Growth | +2.0% | +16.5% | +21.7% |
| Debt/Equity | 0.16 | 0.21 | 0.19 |
Dividend
Dividend Yield1.34%
Annual Dividend$0.21
Payout Ratio66.9%
Frequencyquarterly
Ex-DividendFeb 26, 2026
Pay DateMar 11, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |